Dr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.
| SHARE: | RSS: |  |
LATEST ARTICLES
- Dr. Hersh and a team of eye surgeons visits Bogota, Colombia to perform a new LASIK procedure!
- Dr. Hersh gives lecture at the 8th International Congress of Corneal Cross-Linking held in Geneva
- Dr. Hersh is the ONLY LASIK surgeon at The Cornea and Laser Eye Institute!
- CXL analyses guide treatment
- 2012 Keratoconus Educational Seminar
FEATURED ARTICLES
- Dr. Hersh and a team of eye surgeons visits Bogota, Colombia to perform a new LASIK procedure!
- Dr. Hersh gives lecture at the 8th International Congress of Corneal Cross-Linking held in Geneva
- Dr. Hersh is the ONLY LASIK surgeon at The Cornea and Laser Eye Institute!
- CXL analyses guide treatment
- 2012 Keratoconus Educational Seminar
CATEGORIES
- General (11)
TAGS
BLOG ARCHIVE
- March 2013 (1)
- December 2012 (2)
- July 2012 (2)
- June 2012 (2)
- May 2012 (3)
- April 2012 (1)
LASIk Self-Evaluation Test
Seeking LASIK eye surgery in New Jersey? Find out if you are a LASIK candidate by taking this simple test.
LASIk Self-Evaluation Test
Hear From Our Patients LASIK
"Dr. Hersh and his staff were excellent. I would recommend the Cornea and Laser Eye Institute to anyone."
Luke Petitgout, Pro Athlete
New York Giants Football
Hear From Our Patients LASIK
 |
CXL analyses guide treatmentCreated on: Monday, July 16, 2012 |
Category: General
 |
Dr. Hersh publishes new article in Journal of Refractive Surgery - June 2012 editionCreated on: Wednesday, June 20, 2012 |
Category: General
In the June issue of Journal of Refractive Surgery, Dr. Hersh's article, "Effect of Topographic Cone Location on Outcomes of Corneal Collagen Cross-linking for Keratoconus and Corneal Ectasia." Corneal collagen cross-linking is a treatment designed to decrease the progression of keratoconus and corneal ectasia. The purpose of the article is to assess the effect of preoperative topographic cone location on 1-year outcomes of corneal collagen cross-linking (CXL).
To read the compete article, please click on the link below. If you have keratoconus or corneal ectasia and are interested to see if CXL would benefit you, please call The CLEI Center for Keratoconus at 201-883-0505.
 |
Dr. Peter Hersh presents at The American Society of Cataract and Refractive SurgeryCreated on: Tuesday, April 24, 2012 |
Category: General
Dr. Hersh presented several lectures at the ASCRS symposium in Chicago this past weekend. On Thursday evening, he presented the results of a clinical study looking at the use of intacs in conjuction with corneal collagen crosslinking (CXL) on the treatment of keratoconus and corneal ectasia. On Saturday morning he led the EyeWorld symposium on new advancements on crosslinking where he reviewed the results of the US clinical trials of CXL for keratoconus and corneal ectasia. Saturday afternoon, he gave a course with other investigators in the United States to teach attending ophthalmologists the crosslinking procedure and to review the clinical expectations for those who are just starting to perform crosslinking. At the Monday morning symposium on keratoconus, he discussed the results and patient selection on CXL. All in all, it was a very successful and educational meeting!
